Document Detail


Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion.
MedLine Citation:
PMID:  7908165     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report two patients who experienced severe reversible encephalopathy following infusion of peripheral blood stem cells cryopreserved in 10% dimethylsulfoxide (DMSO). In one patient, reduction of DMSO level with plasmapheresis resulted in marked improvement in encephalopathy. Infusion of large volumes of cryopreserved stem cells may result in a significant toxic reaction. Plasmapheresis may be a treatment option for patients with significant toxicity related to DMSO.
Authors:
M Dhodapkar; S L Goldberg; A Tefferi; M A Gertz
Related Documents :
9070175 - Intraoperative autologous transfusion during elective infrarenal aortic reconstruction.
20185605 - Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated...
2378025 - Incidence of red cell antibodies after multiple blood transfusion.
8611465 - Clinical and laboratory factors associated with platelet transfusion refractoriness: a ...
21819745 - Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-pa) in acute...
18459085 - Short-term changes in hscrp and nt-probnp levels in hypertensive emergencies.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of hematology     Volume:  45     ISSN:  0361-8609     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  1994 Feb 
Date Detail:
Created Date:  1994-04-26     Completed Date:  1994-04-26     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  187-8     Citation Subset:  IM    
Affiliation:
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain Diseases / etiology*,  therapy
Cell Transplantation / adverse effects*
Cryopreservation
Dimethyl Sulfoxide / pharmacology
Hematopoietic Stem Cell Transplantation*
Hematopoietic Stem Cells / drug effects
Humans
Male
Middle Aged
Plasmapheresis
Chemical
Reg. No./Substance:
67-68-5/Dimethyl Sulfoxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohor...
Next Document:  Inhibition by ethanol of the cardiovascular effects of glutamate in the nucleus of the solitary trac...